Novartis AG

NVS · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$11,459$13,393$7,517$12,407
Short-Term Investments$1,892$569$11,098$15,706
Receivables$8,211$9,376$9,894$9,621
Inventory$5,723$5,913$7,175$6,666
Other Curr. Assets$2,419$1,230$1,226$1,318
Total Curr. Assets$29,704$30,481$36,910$45,718
Property Plant & Equip (Net)$10,873$10,924$12,195$13,106
Goodwill$24,756$23,341$29,301$29,595
Intangibles$26,915$26,879$31,644$34,182
Long-Term Investments$1,128$1,827$1,606$2,268
Tax Assets$4,359$4,309$3,739$3,743
Other NC Assets$4,511$2,184$2,058$3,183
Total NC Assets$72,542$69,464$80,543$86,077
Other Assets$0$0$0$0
Total Assets$102,246$99,945$117,453$131,795
Liabilities
Payables$4,572$4,926$5,146$5,553
Short-Term Debt$8,324$6,314$6,127$6,502
Tax Payable$2,225$2,409$3,369$3,034
Deferred Revenue$127$98$123$123
Other Curr. Liab.$13,444$12,643$13,891$14,996
Total Curr. Liab.$28,692$26,390$28,656$30,208
LT Debt$22,934$20,034$21,782$24,523
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,419$2,248$2,686$3,070
Other NC Liab.$4,075$4,523$4,906$6,172
Total NC Liab.$29,428$26,805$29,374$33,765
Other Liabilities$0$0$0$0
Cap. Leases$1,803$1,828$1,789$1,896
Total Liabilities$58,120$53,195$58,030$63,973
Equity
Pref Stock$0$0$0$0
Common Stock$793$825$890$901
Retained Earnings$46,561$49,649$63,540$70,989
AOCI-$3,255-$3,766-$4,996-$4,187
Other Equity-$53-$41-$92-$48
Total Equity$44,046$46,667$59,342$67,655
Supplemental Information
Minority Interest$80$83$81$167
Total Liab. & Tot. Equity$102,246$99,945$117,453$131,795
Net Debt$19,799$12,955$20,392$18,618